| 영문 | toxicity | 한글 | 독성 |
|---|---|---|---|
| 설명 | 생체에 있어 바람직하지 않은 약물 작용을 말한다. 약물을 과량으로 사용하면 중독을 일으키며, 심한 경우에는 죽음에 이르는데 이는 약물의 급성 독성이다. 만성 독성은 소량을 장기간 반복 섭취하였을 때의 독성이다. 간, 콩팥 등 여러 장기와 조직에 대한 독성 외에, 기형유발성, 발암성 등도 약물독성이다. 약물독성의 강약은 급성 독성검사(LD50), 만성 독성검사, 기형유발검사, 발암검사, 번식검사 기타 여러 동물검사에 의해 판정된다. |
||
| 영문 | neonatal intensive care center | 한글 | 신생아 집중치료실 |
|---|---|---|---|
| 설명 | 미숙아나 가사 상태의 출산아를 집중적으로 보살피고 치료하는 기관. |
||
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| CAP | camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab... |
| CAT | California Achievement Test; capillary agglutination test; catalase; cataract; catecholamine; Childr... |
| CHL | Chinese hamster lung; chlorambucil; chloramphenicol |
| CMC | carboxymethylcellulose; care management continuity; carpometacarpal; cell-mediated cytolysis or cyto... |
| CTC | Common Toxicity Criteria |
|---|---|
| DLT | Dose limiting toxicity |
| RRT | Regimen related toxicity |
| TCLP | Toxicity Characteristic Leaching Procedure |
| TIE | Toxicity Identification Evaluation |
| acute toxicity | <pharmacology> Illness resulting from a single dose or exposure to a toxic substance. Compare: chronic toxicity. (06 May 1997) |
|---|---|
| chloramphenicol | <drug> A broad-spectrum antibiotic that inhibits bacterial protein synthesis in prokaryotes and in mitochondria and chloroplasts by acting on the 50S ribosomal subunit. It was first isolated from the fungus like bacterium Streptomyces venezuelae but is now produced synthetically. It is relatively toxic but finds wide application in medicine. (01 Dec 1998) |
| chloramphenicol 3'-O-phosphotransferase | <enzyme> Phosphorylates the 3'-oh position of chloramphenicol producing a metabolite which confers resistance to chloramphenicol when introduced into a chloramphenicol-sensitive host Registry number: EC 2.7.1.- Synonym: cpt protein, cpt gene product (26 Jun 1999) |
| chloramphenicol acetyltransferase | <enzyme> A bacterial enzyme that inactivates the antibiotic chloramphenicol by acetylation. Widely used as a reporter gene for examining the control of eucaryotic gene expression. Acronym: CAT (08 Mar 2000) |
| chloramphenicol acetyltransferase assay | <investigation> A lab technique used to determine whether a given fragment of DNA has a promoter on it to encourage transcription to occur, by attaching the gene (called the CAT gene) which codes for the CAT enzyme to it, and observing whether the CAT enzyme is produced. (05 Jan 1998) |
| chloramphenicol acetyltransferase gene | <molecular biology> A gene which codes for the CAT enzyme (the enzyme chloramphenicol acetyltransferase), which helps transfer an acetyl group (a CH3CO- group) to chloramphenicol, an antibiotic. The CAT gene is an important part of CAT assays. (09 Oct 1997) |
| chloramphenicol amidase | <enzyme> Mouse liver microsomal enzyme which cleaves dichloro-acetyl group from chloramphenicol Registry number: EC 3.5.1.- Synonym: chloramphenicol hydrolase. (26 Jun 1999) |
| chloramphenicol o-acetyltransferase | <enzyme> An enzyme that catalyses the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. Chemical name: Acetyl-CoA-chloramphenicol 3-O-acetyltransferase Registry number: EC 2.3.1.28 (12 Dec 1998) |
| chloramphenicol palmitate | <chemical> Same action and use as chloramphenicol. (05 Mar 2000) |
| chloramphenicol resistance | <microbiology, pharmacology> Nonsusceptibility of a bacterium to the action of chloramphenicol, a potent inhibitor of protein synthesis in the 50s ribosomal subunit where amino acids are added to nascent bacterial polypeptides. (12 Dec 1998) |
| chloramphenicol sodium succinate | <chemical> Chloramphenicol-alpha-(sodium succinate);the water-soluble sodium succinate derivative of chloramphenicol, suitable for parenteral administration; antibacterial activity, uses, and side effects are similar to those of the parent compound. (05 Mar 2000) |
| chronic toxicity | <pharmacology> Illness caused by repeated or long-term exposure to low doses of a toxic substance. Compare: acute toxicity. (09 Oct 1997) |
| digitalis toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| digoxin toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| drug toxicity | The systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug. (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|